| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $311.1M | $306.6M | $295.9M |
| YoY Revenue Growth % | +1.5% | +3.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$160.9M | -$69.8M | -$126.9M |
| Operating Margin % | -51.7% | -22.8% | -42.9% |
| Net Income (GAAP) | -$178.0M | -$69.5M | -$118.1M |
| EBITDA (Normalized) | -$160.1M | -$68.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $731.0K | $14.6M | -$33.1M |
| Capital Expenditures (CapEx) | $968.0K | $1.6M | — |
| Free Cash Flow (FCF) | -$237.0K | $12.9M | -$33.1M |
| FCF Margin % | -0.1% | 4.2% | -11.2% |
| Return on Invested Capital (ROIC %) | -36.7% | -20.7% | — |
| Cash & Short-Term Equivalents | $50.8M | $249.6M | — |
| Total Debt (Short + Long Term) | $151.6M | $151.2M | — |
| Total Stockholders' Equity | $245.8M | $365.2M | — |